Extracellular Biomarkers Summit, March 16-18, 2015  
Extracellular Biomarkers Summit, March 16-18, 2015 
  • Sponsor & Exhibit Opportunities


conference tracks 

MARCH 16-17 

microRNA as Biomarkers and Diagnostics

 
Exosomes and Microvesicles as Biomarkers and Diagnostics

 

MARCH 17-18 

Long Non-Coding RNA in Cancer

 

Extracellular RNA in Drug and Diagnostic Development

 

FEATURED SPEAKERS 

Carlo M. CroceCarlo M. Croce
Director, Genetics Institute
The Ohio State University


Susan FreierSusan Freier
Vice President
Isis Pharmaceuticals



Ajay GoelAjay Goel
Director, Cancer Prevention
Baylor Research Institute

Raghu KalluriRaghu Kalluri
Chair, Cancer Biology
MD Anderson Cancer Center


Omar LaterzaOmar Laterza
Director, Clinical Development Laboratory
Merck


Nicole Meisner-KoberNicole Meisner-Kober
Senior Investigator, RNA Biology
Novartis


DINNER COURSES 

MARCH 16
 

CFDX arrowSystems Biology, Evidence Synthesis and in silico Discovery Approaches to microRNA Biomarkers 

CFDX arrowExecutive ThinkTank: Development of Exosome-Based Diagnostics 

MARCH 17
 

CFDX arrowRNA-Seq: A Fundamental Guide to the Field 

CFDX arrowCirculating Nucleic Acid Biomarkers for Development of Non-Invasive Prenatal Tests
 

ABOUT THE EVENT 

Extracellular Biomarkers Summit, the newest addition to Cambridge Healthtech Institute's notable biomarker and diagnostics portfolio, merges the well-established microRNA as Biomarkers and Diagnostics Conference with focused discussions on three leading areas of research: the role of circulating microRNA, exosomes and microvesicles, long non-coding RNA and extracellular RNA in cancer and other diseases, as well as their potential to serve as biomarkers in drug and diagnostic development. Discussions will include the isolation and characterization of exosomes and exRNA, including expression profiling and sequencing of exRNA; understanding the role of miRNA, lncRNA, and exosomes in disease mechanism, tumor metastasis, and intracellular communication; their potential as biomarkers in drug development, drug toxicity assessment, and patient stratification; and finally, their role as circulating biomarkers for disease diagnosis and prognosis. 

Please join us to gain comprehensive coverage of extracellular biomarkers and hear from industry leaders on cutting-edge research, technologies and applications.